Respiratory drugs
Read the topic background here, then explore the labeled visual and structured learning explanations on this page.
Read explanation on this page ↓ See diagram ↓Bronchodilator — on-site reading
This reference extract addresses Bronchodilator, a related subject. It does not cover every part of Respiratory drugs.. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.
A bronchodilator or broncholytic (although the latter occasionally includes secretory inhibition as well) is a substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs. Bronchodilators may be originating naturally within the body, or they may be medications administered for the treatment of breathing difficulties, usually in the form of inhalers. They are most useful in obstructive lung diseases, of which asthma and chronic obstructive pulmonary disease are the most common conditions. They may be useful in bronchiolitis and bronchiectasis, although this remains somewhat controversial. They are often prescribed but of unproven significance in restrictive lung diseases.
Bronchodilators are either short-acting or long-acting. Short-acting medications provide quick or "rescue" relief from acute bronchoconstriction. Long-acting bronchodilators help to control and prevent symptoms. The three types of prescription bronchodilating drugs are beta-2 adrenergic agonists (short- and long-acting), anticholinergics (short- and long-acting), and theophylline (long-acting).
How this connects to Pharmacology
Pulmonary function combines airway ventilation, alveolar gas exchange, blood perfusion and respiratory-muscle mechanics. Airflow limitation, restricted expansion, impaired diffusion and ventilation–perfusion mismatch are distinct mechanisms that may coexist and require different investigations.
Text credit: Wikipedia contributors, “Bronchodilator”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.
Respiratory drugs · visual study map
Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).
What the underlying subject studies
Pharmacology links a substance’s mechanism to the concentration reaching its target and the resulting physiological effect. Distinguish pharmacokinetics—how exposure changes—from pharmacodynamics—how a target responds.
How mechanisms and evidence connect
Benefits and harms depend on indication, route, dose, patient characteristics, organ function and interactions. A mechanism chart groups medicines for study but does not establish equivalence, superiority or an individual prescription.
How to develop a sound explanation
For each drug or drug class, identify the molecular target, intended effect, major limitations, common classes of adverse effects and how evidence and guidelines inform use. This library intentionally does not provide patient-specific doses or prescribing orders.
References and verification (optional)
All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.
NMC official CBME Curriculum 2024 and current regulations index ↗